Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Will Eli Lilly Stock Continue To Rise After 40% Gains In The Ongoing Inflation Shock?
08:00am, Friday, 30'th Jun 2023
Eli Lilly stock (NYSE: LLY) currently trades at $459 per share, roughly 150% above its level in March 2021.
Eli Lilly to buy Sigilon Therapeutics on a massive premium
01:50pm, Thursday, 29'th Jun 2023
Shares of Sigilon Therapeutics Inc (NASDAQ: SGTX) soared more than 500% today after Eli Lilly & Co (NYSE: LLY) said it will buy the biopharmaceutical company in a deal worth up to $309.6 million. Deta
Eli Lilly to Acquire Sigilon Therapeutics
12:55pm, Thursday, 29'th Jun 2023
Eli Lilly said it will acquire Sigilon Therapeutics in an all-cash deal worth up to $309.6 million.
Eli Lilly's weight loss drug 'sets a new bar' with remarkable Phase 2 results
12:31pm, Thursday, 29'th Jun 2023
Eli Lilly and Co (NYSE:LLY) shares are up again Thursday as its weight loss drug retatrutide continues to garner attention from investors and analysts alike. UBS reiterated its Buy rating and $498
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
10:38am, Thursday, 29'th Jun 2023
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Medicare coverage of weight-loss drugs? Don't count on it, analysts say.
08:32am, Thursday, 29'th Jun 2023
Investors should not bank on Medicare covering the powerful new weight-loss drugs from Eli Lilly & Co. LLY, -1.25%, Novo Nordisk NVO, +0.52% and other drugmakers any time soon, Beacon Policy Advisors
Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments
08:13am, Thursday, 29'th Jun 2023
Eli Lilly and Co said on Thursday it will acquire all the shares of Sigilon Therapeutics that it did not own to gain access to experimental cell therapies that can provide longer-term solutions for di
Better Artificial Intelligence Stock: GSK or Eli Lilly?
03:15pm, Wednesday, 28'th Jun 2023
Artificial intelligence is being used by the world's top drugmakers to speed up innovation in areas of high unmet medical need. GSK and Eli Lilly are both pioneers in the use of AI for drug discovery
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
09:35am, Wednesday, 28'th Jun 2023
Eli Lilly's orforglipron appears to be the top contender in the weight loss pill space due to its strong efficacy data and ease of use.
Lilly, Pfizer and Others Are Working on Obesity Pills. What to Know.
01:35pm, Tuesday, 27'th Jun 2023
Lilly investors are upbeat on injectable weight-loss treatment Mounjaro, but the pills—easier to take, cheaper to make—might have the biggest long-term impact.
Eli Lilly Shares Rise After Drug Helps Patients Lose More Weight Than Competitors
12:50pm, Tuesday, 27'th Jun 2023
Eli Lilly shares rose in early trading on Tuesday after a trial showed its retatrutide weight loss drug could help patients lose more weight than other drugs, including Novo Nordisk's Ozempic.
NVS or LLY: Which Is the Better Value Stock Right Now?
12:48pm, Tuesday, 27'th Jun 2023
Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Novartis (NVS) or Eli Lilly (LLY). But which of these two stocks is more attractive to value investor
Why Eli Lilly Stock Briefly Popped Today
11:33am, Tuesday, 27'th Jun 2023
Eli Lilly may have a best-in-class obesity care asset. In a mid-stage study, the drugmaker's weight loss drug produced a mean weight reduction of 24.2% at 48 weeks.
Eli Lilly Stock Nabs Record on Obesity Drug Trial Data
11:08am, Tuesday, 27'th Jun 2023
Eli Lilly And Co (NYSE:LLY) released mid-stage trial data earlier today showing its obesity drug candidate promoted weight loss of up to 24.2% after 48 weeks, beating competitors' results.
Factbox: Weight-loss drugs: the next gold rush
10:56am, Tuesday, 27'th Jun 2023
Drug developers are chasing an obesity drug gold rush that may be worth up to $100 billion by rolling out treatments that can help lose as much as 24% of weight in less than a year.
